Provided is a pharmaceutical composition which is for treating ulcerative colitis and includes a compound represented by formula (1) or a pharmaceutically acceptable salt thereof, wherein said compound or pharmaceutically acceptable salt thereof is administered to a patient having ulcerative colitis in a dose of at least 600 mg per day.